Boston Scientific develops minimally invasive medical technologies across cardiovascular interventions, cardiac rhythm management, neurology, endoscopy, urology, and pelvic health. Founded in 1979, the company operates in 127 countries with a workforce of over 53,000 people. Its portfolio treats more than 44 million patients annually.
The company invests approximately $1.68 billion per year in research and development, working closely with healthcare professionals to identify clinical needs and develop solutions. This collaborative approach shapes product development across its diverse technology platforms, each designed to improve patient outcomes through minimally invasive approaches.